Her 2 Positive Advanced Breast Cancer Clinical Trials

ReadTheTrial indexes 1 studies for Her 2 Positive Advanced Breast Cancer. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Her 2 Positive Advanced Breast Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Her 2 Positive Advanced Breast Cancer

PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR ERIBULIN MESYLATE) IN HER2-POSITIVE ADVANCED BREAST CANCER

NCT07494448 · NOT YET RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Her 2 Positive Advanced Breast Cancer?

There are 1 clinical trials listed for Her 2 Positive Advanced Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Her 2 Positive Advanced Breast Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Her 2 Positive Advanced Breast Cancer trials in?

Current Her 2 Positive Advanced Breast Cancer trials are distributed across: Phase 2 (1).

Find More Trials